fda approved glp 1 for weight loss The a new GLP-1 pill called Foundayo (orforglipron) adults with obesity or who are overweight and have weight-related health issues: https://bit.ly/4toaoTl FDA Approves Oral Semaglutide as
Description
Here is what a well-designed GLP-1 protocol looks like when you have Hashimoto's thyroiditis
Because pill-based GLP-1 options are easier to initiate, providers may consider them sooner in the disease progression
The most common side effects of GLP-1s are nausea, vomiting, diarrhea, and abdominal pain
Klausen et al
in clinical studies, an increase in hypoglycemia incidence was only observed in tirzepatide-treated patients if they had a comedication with insulin and/or oral insulinotropic agents (sulfonylurea) (61)
doi: 10.7150/ijbs.59965
